Navigation Links
A Boy Undergoing Treatment For Cancer Gets AIDS At AIIMS

The Delhi High Court, which is angered by the defence attorneys of the AIIMS hospital, has sought an immediate explanation from the medical superintendent// about the case where a boy, suffering from cancer, got inflicted with AIDS after blood transfusion at the hospital in 2001.

The victim, who was nine years old at the time of his admission to the hospital in July 2000 for treatment of cancer, supposedly has contracted HIV due to transfusion of contaminated blood. His father in 2001 filed a writ petition in the High Court seeking compensation of Rs 25 lakh for the grave mistake. The authorities at AIIMS have denied the charge as baseless, but at the same time they are unwilling to divulge the identity of the donor whose blood was transfused to the victim. The boy was then nine-years-old.

The court is know asking them to explain as to why the hospital is not ready to disclose details of the donor whose blood was transfused into the victim. Justice Vikramjit Sen while stating that the issue of blood transfusion concerns the public at large, he said, that the medical superintendent needs to explain as to how an hospital can protect a person whose contaminated blood has inflicted HIV in a person.

Justice Sen was perturbed and angered after the AIIMS counsel tried to argue the matter on technical grounds. Objecting to the advocate's arguments, the judge commented that in most of the cases where AIIMS was involved, the hospital would get defensive and refuses to admit the fault. While asking as to why the hospital's counsel were they trying to shield the donor, he remarked, "I agreethat the hospital is of repute and has the best facilities. But it can go wrong somewhere”. He further brushed aside the hospital's arguments that the boy must have received the virus through a needle or an intravenous drug. He strongly asked as to whether the councils meant that the nine-year-old boy was on drugs.

According to Anand Gr
'"/>




Page: 1 2

Related medicine news :

1. Avoid Coffee Before Undergoing PET/ CT scans
2. AIDS Drug Found To Help Patients Undergoing Chemotherapy
3. Patients Undergoing Breast Radiation Are Facing Complications
4. Togadiyas Condition Stable After Undergoing Angioplasty
5. Women Compensated For Losing Eye-Sight After Undergoing Cataract Operation
6. Drug Therapy Offers Little Benefit for Some Patients Undergoing Angioplasty or Stent Procedure
7. Special Diets Necessary for Those Undergoing Chemotherapy
8. Asians in US Increasingly Undergoing Plastic Surgery to Look White
9. Women Suggested to Consult Doctors Before Undergoing Routine Mammography
10. Advances in Treatment of Cataracts
11. Recommendations for Treatment of Blood Pressue
Post Your Comments:
(Date:8/20/2008)...ewswire/ -- Governor Edward,G. Rendell today said ...,with high fuel costs and a broken healthcare syst...ergy independence and make healthcare more,afforda...ed to hear the Governor,s message at the,Governmen...nsylvania,s,largest outdoor agricultural expositio...
(Date:8/20/2008)...art of a new generation of neurosurgeons who are m...At Loyola University Hospital, Duckworth is using ...ir life-threatening aneurysms and to dramatically ...han removing large sections of the skull or face, ...er openings. And in certain cases, he goes through...
(Date:8/20/2008).../ -- Yesterday evening,Congresswoman Stephanie Tu...fering an aneurysm while driving her car in Clevel...Jones, condition has stabilized and she is,receivi...followed a full day of activity, including plannin...uled for September 4, 2008,at Cleveland State Univ...
(Date:8/20/2008)...alth technologies designed to,monitor and care for...s in,excess of $1.8 billion by 2013., Technologic...hardware,revenues, according to Parks Associates, ...ogies. Connected medical, activity, and environmen...ring in more than twice the,dollar amount of the l...
Breaking Medicine News(10 mins):Health News:Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days 2Health News:Brain surgery is getting easier on patients 2Health News:Brain surgery is getting easier on patients 3Health News:Service and Hardware Revenues Will Contribute $1.8 Billion to the U.S. Eldercare Industry by 2013 2
...entists warn that passive smokings from cigarette ...entists have now detected the cancer-causing chemi...in the urine of nearly half the babies whose paren...e message is, 'Don't smoke around your kids,'" sai...
...tudy states that the organ donation rate in UK is ...ieving relatives are reluctant to allow such proce...re blocking the wishes of potential organ donors b...d about what their loved-ones would have wanted, c...
.... health officials suspect the abortion pill, RU-4...erial infections. //Out of the 6 women who took th...or RU-486 is now expected to be pulled from the sh...ibuted their deaths to the drug. The rare bacteriu...
...ording to a recent study conducted by the research...as found that one in seven East Asian immigrants a...ispose them to conditions such as liver cancer and...t of the people are unaware that they were infecte...
Other Medicine News:Health News:Cancer Causing Chemicals Found In Urine Of Babies Whose Parents Smoke 2Health News:Grieving Relatives Reluctant To Give Consent For Organ Donation 2Health News:East Asian Immigrants Bring Hepatitis to New York 2
(Date:8/14/2008)...INGAPORE, Aug. 15 /- AstraZ...new partnership with the National Cancer,Centre Si...l (NUH) to,develop anti-cancer compounds. The coll...nderstanding (MOU) that was signed today, aims to ...ilities in Asia and ultimately,speed up access to ...
(Date:8/14/2008)...st T cell engaging antibody (BiTE) showing clinica... patients own T cells to recognize and attack ...Md., Aug. 14 /- Micromet, I...developing novel, proprietary,antibodies for the t...seases, today announced publication of a Phase 1 c...
(Date:8/14/2008)... - Phase 2 development to begin in late 2008 or i...wswire-FirstCall/ -- Nuvelo, Inc.,(Nasdaq: NUVO )...b,proof-of-concept trial of NU172, demonstrating t... and maintained anticoagulation with a rapid,retur...favorable safety,profile., "NU172 has the potenti...
(Date:8/13/2008)...igh Omega-3 Fat Intake Improves Insulin Sensitivit...lter Endocrine Responsiveness, PHOENIX, Aug. 13 /...enix-based Kronos Longevity Research Institute (KL... insulin sensitivity and reduces inflammatory,mark...This study was,recently published in Hormones and ...
Breaking Medicine Technology:AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Study Shows Benefits of a High Omega-3 Diet in Older Adults 2Study Shows Benefits of a High Omega-3 Diet in Older Adults 3Biophysical Society announces winners of 2008 Minority Travel Awards 1714 1Biophysical Society announces winners of 2008 Minority Travel Awards 1714 2Kids in Poor Neighborhoods Fall Behind in School 8726 1Kids in Poor Neighborhoods Fall Behind in School 8726 2Songbirds offer clues to highly practiced motor skills in humans 8724 1Songbirds offer clues to highly practiced motor skills in humans 8724 2Songbirds offer clues to highly practiced motor skills in humans 8724 3Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America 8720 1Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America 8720 2
.../ -- A new Harris Poll,suggests that the flu vacci...ctive than the vaccines used in some previous year... were only 24 percent,less likely to get the flu t... were larger in two previous Harris Polls on the s.../2005 adults who were,vaccinated were 33 percent a...
...udy showed significant,results in favor of alemtuz...., May 02, 2007,/PRNewswire-FirstCall/ -- Genzyme ...day announced detailed interim results from the,CA... patient data,through at least twenty-four months ...d that a once-yearly cycle of alemtuzumab,treatmen...
Other Medicine Technology:Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 2Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 3Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 4Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 5Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 6Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 2Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 3Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 4Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 5Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 6Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 7Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 8Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 9
Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles.
Heine Beta 200 Streak Retinoscope 3.5v
Video Equipment
Micro-mini fiber optic light.
Medicine Products: